Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00526136
Status:
COMPLETED
Last Update Posted:
2008-12-18
First Post:
2007-09-05
Brief Title:
Vernakalant Oral Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
Sponsor:
Advanz Pharma
Organization:
Advanz Pharma
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Atrial Fibrillation |
Keywords:
| Name | View |
|---|---|
| Atrial Fibrillation | View |